BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 22237979)

  • 1. Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts.
    Knower KC; To SQ; Takagi K; Miki Y; Sasano H; Simpson ER; Clyne CD
    Breast Cancer Res Treat; 2012 Apr; 132(2):765-71. PubMed ID: 22237979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts.
    Chand AL; Herridge KA; Howard TL; Simpson ER; Clyne CD
    Steroids; 2011 Jul; 76(8):741-4. PubMed ID: 21392518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
    Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase in aging women.
    Bulun SE; Zeitoun K; Sasano H; Simpson ER
    Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
    Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
    Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.
    Chen D; Reierstad S; Lin Z; Lu M; Brooks C; Li N; Innes J; Bulun SE
    Cancer Res; 2007 Sep; 67(18):8914-22. PubMed ID: 17875734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.
    Ghosh S; Lu Y; Katz A; Hu Y; Li R
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E246-52. PubMed ID: 16940470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast.
    Zhang Z; Yamashita H; Toyama T; Omoto Y; Sugiura H; Hara Y; Wu X; Kobayashi S; Iwase H
    Breast Cancer Res; 2003; 5(6):R250-6. PubMed ID: 14580261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylseleninic acid is a novel suppressor of aromatase expression.
    Gao R; Zhao L; Liu X; Rowan BG; Wabitsch M; Edwards DP; Nishi Y; Yanase T; Yu Q; Dong Y
    J Endocrinol; 2012 Feb; 212(2):199-205. PubMed ID: 22128327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts.
    Knower KC; To SQ; Simpson ER; Clyne CD
    Mol Cell Endocrinol; 2010 Jun; 321(2):123-30. PubMed ID: 20211687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose.
    To SQ; Simpson ER; Knower KC; Clyne CD
    Breast Cancer Res Treat; 2013 Feb; 138(1):193-203. PubMed ID: 23338760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin receptors, melatonin metabolizing enzymes and cyclin D1 in human breast cancer.
    Rögelsperger O; Wlcek K; Ekmekcioglu C; Humpeler S; Svoboda M; Königsberg R; Klimpfinger M; Jäger W; Thalhammer T
    J Recept Signal Transduct Res; 2011 Apr; 31(2):180-7. PubMed ID: 21385053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
    Zhou D; Zhou C; Chen S
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of breast cancer-associated aromatase promoters.
    Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
    Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: a novel mechanism for the regulation of aromatase in obesity and breast cancer.
    Wang X; Docanto MM; Sasano H; ; Lo C; Simpson ER; Brown KA
    Cancer Res; 2015 Feb; 75(4):645-55. PubMed ID: 25634217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.